CombiMatrix Corporation Stockholders Approve Merger Agreement With Invitae Corporation
November 10, 2017 16:15 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results
November 06, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reminds Shareholders to Vote "FOR" the Merger With Invitae Corporation
November 02, 2017 16:55 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote "FOR" the Proposed Merger with Invitae Corporation
November 01, 2017 16:05 ET
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) ("CombiMatrix" or the "Company"), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix to Present New Data from a Large-Scale Analysis of Genomic Abnormalities Impacting Multiple Stages of Human Growth and Development Starting from Conception through Childhood at the American Society of Human Genetics Annual Meeting
October 20, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 20, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae
September 25, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Sept. 25, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) (“CombiMatrix” or the “Company”), a family health molecular diagnostics company specializing in DNA-based...
CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results
August 03, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock
July 31, 2017 16:58 ET
|
CombiMatrix Corporation
$27 million offered to holders of CombiMatrix Common Stock (Nasdaq: CBMX) subject to certain adjustments $6 million offered to holders of CombiMatrix Series F Warrants (Nasdaq: CBMXW) IRVINE,...
CombiMatrix to Present at Upcoming Investor Conferences
May 22, 2017 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., May 22, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results
May 04, 2017 16:05 ET
|
CombiMatrix Corporation
Achieves record reproductive health revenues on higher test volumes and average revenue per test, expands gross margin, significantly narrows operating loss and reports record cash collections ...